Kos to Present at the UBS Global Life Sciences Conference
19 September 2006 - 1:00PM
Business Wire
Kos Pharmaceuticals, Inc. (Nasdaq:KOSP) today announced that Adrian
Adams, President and Chief Executive Officer, will present at the
UBS Global Life Sciences Conference, which is being held September
25 - September 28, 2006 in New York, NY. Kos' presentation will
take place at 1:30 p.m. ET on Monday, September 25, 2006.
Interested parties can access the webcast information by going to
the investor relations section of Kos' website at www.kospharm.com,
and referencing upcoming events. About Kos Kos Pharmaceuticals,
Inc. is a fully integrated specialty pharmaceutical company engaged
in developing, commercializing, manufacturing and marketing
proprietary prescription products for the treatment of chronic
diseases with a particular focus on the cardiovascular, metabolic
and respiratory disease areas. The Company's principal product
development strategy is to reformulate existing pharmaceutical
products with large market potential to improve safety, efficacy,
and patient compliance. Kos' strategy also includes making measured
investments in new chemical entity research through in-house and
sponsored research, scientific in-licensing and general corporate
development activities. The Company currently markets Niaspan(R),
Advicor(R), Azmacort(R), Cardizem(R)LA, Teveten(R) and
Teveten(R)HCT.
Kos (NASDAQ:KOSP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Kos (NASDAQ:KOSP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Kos Pharmaceuticals (NASDAQ): 0 Nachrichtenartikel
Weitere Kos Pharmaceuticals, Inc. News-Artikel